BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16909225)

  • 1. (124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution.
    Bockisch A; Freudenberg L; Rosenbaum S; Jentzen W
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1247-8. PubMed ID: 16909225
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-standard PET radionuclides: time to get ready for new clinical PET strategies.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):294-300. PubMed ID: 17187284
    [No Abstract]   [Full Text] [Related]  

  • 3. Production of iodine-124 and its applications in nuclear medicine.
    Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR
    Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.
    Cerqueira M; Case J; Maddahi J
    J Nucl Cardiol; 2015 Aug; 22(4):730-9. PubMed ID: 26129941
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging of myocardial fatty acid metabolism with PET.
    Bergmann SR
    J Nucl Cardiol; 2007; 14(3 Suppl):S118-24. PubMed ID: 17556179
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel tracers and their development for the imaging of metastatic prostate cancer.
    Apolo AB; Pandit-Taskar N; Morris MJ
    J Nucl Med; 2008 Dec; 49(12):2031-41. PubMed ID: 18997047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the short-lived non-pure positron-emitting nuclide (120)I for PET imaging.
    Herzog H; Qaim SM; Tellmann L; Spellerberg S; Kruecker D; Coenen HH
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1249-57. PubMed ID: 16845512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in pharmaceutical radiochemistry for molecular PET imaging.
    Prante O; Haubner R; Riss P; Neumaier B
    Biomed Res Int; 2014; 2014():890540. PubMed ID: 25328892
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and evaluation of l-5-(2-[(18)F]fluoroethoxy)tryptophan as a new PET tracer.
    Li R; Wu SC; Wang SC; Fu Z; Dang Y; Huo L
    Appl Radiat Isot; 2010 Feb; 68(2):303-8. PubMed ID: 19906535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody.
    Robinson MK; Doss M; Shaller C; Narayanan D; Marks JD; Adler LP; González Trotter DE; Adams GP
    Cancer Res; 2005 Feb; 65(4):1471-8. PubMed ID: 15735035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of PET imaging with radiolabelled choline (11C/18F-choline).
    Kirienko M; Sollini M; Lopci E; Versari A; Chiti A
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):83-94. PubMed ID: 25677590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-124: a promising positron emitter for organic PET chemistry.
    Koehler L; Gagnon K; McQuarrie S; Wuest F
    Molecules; 2010 Apr; 15(4):2686-718. PubMed ID: 20428073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
    Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
    Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis of N-[(11)C]-methyl-hydroxyfasudil as a new potential PET radiotracer for rho-kinases (ROCKs).
    Valdivia AC; Mason S; Collins J; Buckley KR; Coletta P; Beanlands RS; Dasilva JN
    Appl Radiat Isot; 2010 Feb; 68(2):325-8. PubMed ID: 19939685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
    Ruangma A; Bai B; Lewis JS; Sun X; Welch MJ; Leahy R; Laforest R
    Nucl Med Biol; 2006 Feb; 33(2):217-26. PubMed ID: 16546676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Realizing the full potential of PET for measuring the biodistribution of novel anticancer agents.
    Jones T; Price P; Tavitian B
    J Nucl Med; 2011 Sep; 52(9):1500. PubMed ID: 21824989
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.
    Meyer JP; Probst KC; Westwell AD
    J Labelled Comp Radiopharm; 2014 May; 57(5):333-7. PubMed ID: 24692121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling of antibiotics for infection diagnosis.
    Benitez A; Roca M; Martin-Comin J
    Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):147-52. PubMed ID: 16770305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracer development and hybrid imaging.
    Yang DJ; Kim EE
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1001-2. PubMed ID: 16086160
    [No Abstract]   [Full Text] [Related]  

  • 20. Triaryl (Z)-olefins suitable for radiolabeling with iodine-124 or fluorine-18 radionuclides for positron emission tomography imaging of estrogen positive breast tumors.
    Abdellatif KR; Velázquez CA; Huang Z; Chowdhury MA; Knaus EE
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1195-8. PubMed ID: 21237640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.